Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Lecce – page 8

89 clinical trials in Lecce, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Lecce at a glance
89
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

89 trials in Lecce

Open in trial search
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Incyte Corp.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Celgene Corp.
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer Ginecologico

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Lecce

What the registry says about research in the country

01 Oncology Research

Extensive clinical trials focusing on colorectal cancer and innovative treatment approaches combining immunotherapy with established treatments. Studies evaluating new therapeutic strategies for metastatic diseases.

  • Colorectal Cancer Treatments
  • Immunotherapy Combinations
  • Metastatic Disease Management

Multiple studies exploring targeted therapies and novel drug combinations.

02 Hematologic Malignancies

Cutting-edge research in leukemia treatment, including studies on acute myeloid leukemia and chronic myeloid conditions. Innovative approaches testing new drug combinations and treatment strategies.

  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma

Focus on improving patient outcomes through targeted therapies.

03 Diagnostic Innovation

Advanced research in diagnostic imaging and biomarker studies, particularly in prostate cancer and other solid tumors. Development of precise diagnostic tools for early detection and treatment monitoring.

  • PET Imaging Studies
  • Biomarker Research
  • Treatment Response Assessment

Emphasis on improving diagnostic accuracy and treatment selection.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.